Achaogen (AKAO) Misses Q1 EPS by 17c, Beats on Revenues

Achaogen (NASDAQ: AKAO) reported Q1 EPS of ($1.06), $0.17 worse than the analyst estimate of ($0.89). Revenue for the quarter came in at $2.14 million versus the consensus estimate of $1.14 million.

For earnings history and earnings-related data on Achaogen (AKAO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c